Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 944 results for "cipla india"

Cipla to launch generic Hepatitis C drug 'Hepcvir' in India

Cipla to launch generic Hepatitis C drug 'Hepcvir' in India

The availability of product in other markets is subject to approvals from the regulatory authorities in respective countries, Cipla said. DNA, 2 days ago

18 images for cipla india

India TV, 2 days ago
NDTV Profit, 2 days ago, 2 weeks ago, 2 days ago
India Infoline, 2 days ago
Sify, 1 day ago
DNA, 1 day ago
First, 2 weeks ago
CFO South Africa, 1 month ago
Pharma Letter, 1 month ago

Boehringer Ingelheim loses patent battle with India's Cipla

German pharmaceutical company Boehringer Ingelheim (Boehringer) has lost its patent on the Spiriva respiratory drug in India. The Indian patent office has agreed with the Indian drugmaker Cipla that Boehringer's Spiriva patent was obvious and was ...
 GaBi Online1 week ago SECTION 3(d) STRIKES AGAIN  PharmaBiz1 week ago Lupin to buy rest of SA drug firm  BDlive1 week ago The long & short of patent war in India [DNA : Sunday]  Pharmacy Choice1 week ago
Money Control

Nifty ends below 8950; Sun Pharma, HUL top gainers

Sun Pharma, HUL, HDFC twins and Cipla were top gainers in the Sensex. Hindalco, Coal India, GAIL, TCS and Sesa Sterlite are major laggards.
 Money Control3 weeks ago Nifty races towards 9000; oil, pharma stocks add strength  Money Control3 weeks ago Sensex, Nifty flat; Coal India falls 5%, Sun Pharma up 2%  Money Control3 weeks ago Nifty ends above 8700, Sensex up 271 pts; BHEL gains 5%  Money Control1 month ago

Sensex down 26 pts after flat start; Cipla, Bharti Airtel move higher

The Indian stock market opened on a flat note this morning, with investors treading cautiously after Monday's sharp setback. Though global cues are slightly positive, investors appear a bit reluctant to lap up stocks amid uncertainty about the near ...
 Sify2 weeks ago Sensex opens flat; Cipla, Bharti, BHEL gain  MyIris2 weeks ago Sensex Sees Flat Opening Amid Mixed Global Cues  RTTNews.com2 weeks ago

Cipla revs up for generic Sovaldi launch in India

Gilead's Sovaldi--Courtesy of Gilead Cipla is rolling out its low-cost version of Gilead Sciences' ($GILD) hep C powerhouse Sovaldi in India. With a launch planned this week, Cipla will become the latest company to field a Sovaldi copycat under ...
 FiercePharma1 day ago UPDATE: First off the blocks, Natco gets India's regulatory nod for hep C copy  FiercePharma2 weeks ago Natco Pharma ties up with Gilead on hepatitis C drug  Times of India3 weeks ago Gilead Sciences, Inc. Signs Deal With Natco Pharma To Develop Generic HCV Drugs  Bidness Etc3 weeks ago
Business Standard

Six in Sixty: Stocks you should keep on your radar

CNBC-TV18's Ekta Batra lists out stocks that you should focus on – SBI, MM, BPCL, Lupin, BHEL, Coal India, Cipla, Sun Pharma, HDFC Bank, ONGC
 Money Control1 month ago Stocks in news: SBI, MM, BHEL, Coal India, ICICI, Cipla  Money Control1 month ago Pre Market: CPI, IIP numbers in focus  Business Standard1 month ago BHEL, Coal India results in focus  India Infoline1 month ago

Here are top 10 stocks to focus on February 13

Here are top 10 stocks to focus on February 13 - Eicher Motor, Zee Entertainment, BHEL, Coal India, Cipla, Lanco Infra, Tata Communications, Gitanjali Gems, Mangalore Chemicals Fertilisers and Pipavav.
 Money Control1 month ago Here are top 10 stocks to keep an eye on February 6  Money Control1 month ago

Stocks in news: Maruti, Thomas Cook, Cairn, Gujarat Fluoro

Maruti Suzuki | Hero Motocorp | Jindal Steel | Thomas Cook | Cairn India | Asian Paints | NMDC | Cipla | SBI | Oudh Sugar Mills | Cholamandalam Finance | Gujarat Fluorochemicals | Ultracab | Reliance Infrastructure | Pipavav Defence | LT Foods | KRBL and GMR ...
 Money Control2 weeks ago

Buy HUL, Dabur, Cipla, Glenmark: CK Narayan

According to CK Narayan, MD at Growth Avenues, one can buy Hindustan Unilever, Dabur India, Cipla and Glenmark Pharma.
 Money Control2 weeks ago

HC notice to Novartis on Cipla plea

Delhi High Court today sought the response of Switzerland-based drug major Novartis AG on the plea of Indian pharma firm Cipla against an order restraining it from making its respiratory disease drug, Indaflo, till it obtains a compulsory licence. A bench of ...
 Deccan Herald2 months ago Delhi HC notice to Novartis on Cipla plea  Nerve2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less